site stats

Rachel lenington athira

WebNovember 10, 2024. Athira Pharma Reports Third Quarter 2024 Financial Results and Business Update. Completed enrollment of ACT-AD trial with topline data expected in the first half of 2024; LIFT-AD is actively recruiting with topline data expected by the end of 2024 – – Presented program updates and baseline data from ATH-1017’s ongoing Phase 2 and … WebJun 14, 2024 · Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy. share: Share on Facebook Tweet on Twitter Post to …

Rachel Lenington - Biography

WebJun 14, 2024 · BOTHELL, Wash., June 14, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Rachel Lenington as Chief Technology Officer, Head of Product … WebOct 21, 2024 · Special Committee of the Board of Directors has concluded its investigation of Dr. Leen Kawas’s Doctoral ResearchConference call to be held October 21, 2024 at 4:30 pm ET BOTHELL, Wash., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small … qnb international transfer form https://login-informatica.com

Athira Pharma Announces Leadership Changes; Mark Litton, Ph.D., …

WebRachel Lenington is the Chief Operating Officer at Athira Pharma. Rachel Lenington attended Pepperdine Graziadio Business School. WebJun 15, 2024 · June 15, 2024. Rachel Lenington. BOTHELL, Wash., June 14, 2024 (GLOBE NEWSWIRE) — Athira Pharma a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Rachel Lenington as Chief Technology Officer, Head of … WebSpecial Committee of the Board of Directors has concluded its investigation of Dr. Leen Kawas’s Doctoral ResearchConference call to be held October 21, 2024 at 4:30 pm ETBOTHELL, Wash., Oct. 21 ... qnb indonesia organization structure

Athira Pharma Appoints Rachel Lenington as Chief Technology

Category:ATHA Athira Pharma Inc. Stock Overview (U.S.: Nasdaq) Barron

Tags:Rachel lenington athira

Rachel lenington athira

Rachel Lenington

WebJun 14, 2024 · Ms. Lenington added, “I am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of … WebRachel Lenington is Chief Operating Officer at Athira Pharma Inc. See Rachel Lenington's compensation, career history, education, & memberships.

Rachel lenington athira

Did you know?

WebJun 14, 2024 · Ms. Lenington added, “I am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of … WebOct 21, 2024 · Rachel Lenington, M.B.A., the Company’s Chief Technology Officer and Head of Product Development Strategy, has been appointed as the Company’s Chief Operating …

WebCompany profile for Athira Pharma Inc. including key executives, insider trading, ownership, ... Rachel Lenington Chief Operating Officer: 4193: Disposition at $ 2.69 per share: 11,279: WebRachel Lenington. Chief Operating Officer. Rachel brings extensive strategic and operational leadership experience in drug development, commercialization and launch to Athira. …

WebJun 15, 2024 · June 15, 2024. Rachel Lenington. BOTHELL, Wash., June 14, 2024 (GLOBE NEWSWIRE) — Athira Pharma a late clinical-stage biopharmaceutical company focused … WebAug 17, 2024 · In addition to Litton’s appointment, former Seagen exec Rachel Lenington, MBA, has been appointed as the company’s Chief Technology Officer and Head of Product Development Strategy. In addition, Mark Worthington, J.D., was recently appointed as Athira’s General Counsel.

WebJun 14, 2024 · Ms. Lenington added, “I am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of helping patients ...

WebAug 16, 2024 · Athira made further leadership changes following the the recent death of board chair Tadataka Yamada. ... New Athira execs Mark Worthington, general counsel, … qnb head office dohaWebJun 22, 2024 · Athira Pharma announces Rachel Lenington as the Chief Technology Officer, Head of Product Development Strategy. FREMONT, CA: Athira Pharma, Inc., a late clinical … qnb helplineWebChief Operating Officer. Athira Pharma. Oct 2024 - Present1 year 7 months. Greater Seattle Area. Lead strategy and operations at Athira Pharma, a … qnb invest hisse girişWebOct 22, 2024 · Courtesy of Athira Pharma. Shares of Athira Pharma are rapidly climbing in premarket trading after the company announced it has ousted Leen Kawas from her role as chief executive officer following the conclusion of an investigation into data manipulation charges surrounding her doctoral research.. In June, Kawas was placed on a temporary … qnb headquartersWebI am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of helping… 68 comments on LinkedIn … qnb health insuranceWebCurrently, Rachel Lenington occupies the position of Chief Operating Officer at Athira Pharma, Inc. Ms. Lenington previously occupied the position of Director & Manager-Global Program at Amgen, Inc., Senior VP-Program & Portfolio Management at Seagen Inc. and Deputy Director-Strategy, Planning & Management at Bill & Melinda Gates Foundation. qnb internshipWebOct 22, 2024 · Rachel Lenington, chief technology officer, will step into Litton's former position. Athira said its lead asset, an experimental Alzheimer's drug called ATH-1017, was not the subject of Kawas ... qnb history